1998 Clinical and Scientific Meeting

Rosamund Vallings MBBS

140 North Road
RD2 Papakura
New Zealand

The Use of Serine in The Management of CFS

Urinary serine levels were checked and found to be low in 7 patients whose illness fitted the CDC criteria for a diagnosis of Chronic Fatigue Syndrome.(1) A low serine level has previously been identified as a possible urinary marker (previously known as CFSUM2) for CFS.(2) Serine was prescribed in a dose of 500mg twice daily to these people. A metabolic screening questionnaire was administered before and after one month of use.

The results of the screening questionnaire and the outcome of the treatment will be presented.

References:
Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Int Med,1994,121, 953-959

McGregor N.R, et al: Preliminary determination of a molecuar basis to chronic fatigue syndrome. Biochemical and Molecular Medicine, 1996, 57, 73-80

 

Alison Hunter Memorial Foundation
PO Box 6132 North Sydney 2059 Australia
Phone/Fax +61 2 9958 6285

Home
About Us
About ME/CFS
Severity
Advocacy
Research
Guidelines
Conferences
Medical Politics
Media
Archives
Links
Donations